학술논문

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

Document Type

article

Author

Chapman, PB; Robert, C; Larkin, J; Haanen, JB; Ribas, A; Hogg, D; Hamid, O; Ascierto, PA; Testori, A; Lorigan, PC; Dummer, R; Sosman, JA; Flaherty, KT; Chang, I; Coleman, S; Caro, I; Hauschild, A; McArthur, GA

Source

Annals of Oncology. 28(10)

Subject

Clinical Research
Cancer
Clinical Trials and Supportive Activities
6.1 Pharmaceuticals
Evaluation of treatments and therapeutic interventions
Adolescent
Adult
Aged
Aged
80 and over
Antineoplastic Agents
Antineoplastic Agents
Alkylating
Dacarbazine
Enzyme Inhibitors
Female
Humans
Indoles
Kaplan-Meier Estimate
Male
Melanoma
Middle Aged
Mutation
Proto-Oncogene Proteins B-raf
Skin Neoplasms
Sulfonamides
Treatment Outcome
Vemurafenib
Young Adult
Oncology and Carcinogenesis
Oncology & Carcinogenesis

Language

Online Access

Open Access (eScholarship) Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송